Cortisol and COVID-19—Putting Undue Stress on the “Stress Hormone”
US Endocrinology
; 16(2):66-67, 2020.
Article
in English
| Scopus | ID: covidwho-1090118
ABSTRACT
Serum cortisol is a measure of underlying disease severity. The more severe the disease, the higher the circulating cortisol levels and the greater the chances of poor prognosis/mortality. Not surprisingly, a recent study found that higher serum cortisol was associated with poor prognosis in patients with coronavirus disease 2019 (COVID-19). Nevertheless, the study did not take into consideration the confounding effect of COVID-19 severity;hence, the results could not be regarded as being fully adjusted. Besides, guiding glucocorticoid therapy based on serum cortisol levels is an impractical proposition, and to date is not backed by robust evidence. Therefore, routine measurement of serum cortisol in patients with COVID-19 is a futile endeavor and should not be encouraged. © Touch Medical Media 2020
Full text:
Available
Collection:
Databases of international organizations
Database:
Scopus
Language:
English
Journal:
US Endocrinology
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS